Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
Abstract People with cardiovascular disease (CVD) often contract coronavirus disease 2019 (COVID‐19). However, the interaction between COVID‐19 and CVD is unclear. In this systematic review, the available evidence for the crosstalk between COVID‐19 and CVD and its treatment was analysed. A search wa...
Main Authors: | Qing Ye, Dezhao Lu, Shiqiang Shang, Junfen Fu, Fangqi Gong, Qiang Shu, Jianhua Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12960 |
Similar Items
-
Progress of angiotensin converting enzyme 2 in cardiovascular diseases
by: JIAO Xiao-lu, QIN Yan-wen
Published: (2020-05-01) -
Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01) -
Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01) -
RAA System and Exercise Relationship
by: Sadettin Ünsal, et al.
Published: (2019-09-01) -
The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)